Towards Healthcare
Insulin Pump Market
Updated Date: 03 February 2026   |   Report Code: 5025
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

Insulin Pump Market Forecast and Analysis (2026-2035)

Projections indicate the global insulin pump market will increase from USD 7.53 billion in 2025 to USD 18.93 billion by 2035, experiencing a growth over the next 10 years. The insulin pump market is growing rapidly, driven by rising diabetes cases, technological advances like smartphone integration, and demand for user-friendly, minimally invasive devices. Emerging trends include artificial intelligence, closed-loop systems, and expanding adoption in developing regions.

Last Updated : 03 February 2026 Category: Medical Devices Insight Code: 5025 Format: PDF / PPT / Excel

Content

Executive Summary

  • Market Snapshot
  • Key Trends
  • Market Dynamics
  • Summary of Key Findings

Introduction

  • Definition and Scope
  • Research Methodology
  • Assumptions and Limitations

Market Dynamics

  • Drivers
    • Increasing Prevalence of Diabetes
    • Technological Advancements
    • Growing Awareness and Adoption
  • Restraints
    • High Cost of Insulin Pumps
    • Reimbursement Issues
  • Opportunities
    • Emerging Markets
    • Innovations in Insulin Delivery Systems
  • Challenges
    • Regulatory Hurdles
    • Market Competition

Market Segmentation

  • By Pump Type (Value and Volume)
    • Tethered Pump
    • Patch Pump
    • Implanted Insulin Pump
    • Closed Loop Insulin Pump
  • By Product (Value and Volume)
    • MiniMed (630G, 670G, and VEO)
    • Accu-Chek (Combo, Insight, and Solo)
    • Tandem (T: slim X2, G4, T: flex Delivery System)
    • Omnipod
    • My life omnipod
    • Others
  • By Application (Value and Volume)
    • Battery
    • Insulin Set Insertion Devices
    • Insulin Reservoir
  • By Disease Indication (Value and Volume)
    • Type 1 Diabetes
    • Type 2 Diabetes
  • By End User (Value and Volume)
    • Hospitals
    • Clinics
    • Homecare
    • Laboratories
  • By Geography (Value and Volume)
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
    • Rest of the World

Detailed Cross-Segment Analysis

Pump Type vs. Product

  • Tethered Pump
    • MiniMed (630G, 670G, and VEO)
      • Value: $X billion
      • Volume: X units
    • Accu-Chek (Combo, Insight, and Solo)
      • Value: $X billion
      • Volume: X units
    • Tandem (T: slim X2, G4, T: flex Delivery System)
      • Value: $X billion
      • Volume: X units
    • Omnipod
      • Value: $X billion
      • Volume: X units
    • My life omnipod
      • Value: $X billion
      • Volume: X units
    • Others
      • Value: $X billion
      • Volume: X units
  • Patch Pump
    • MiniMed (630G, 670G, and VEO)
      • Value: $X billion
      • Volume: X units
    • Accu-Chek (Combo, Insight, and Solo)
      • Value: $X billion
      • Volume: X units
    • Tandem (T: slim X2, G4, T: flex Delivery System)
      • Value: $X billion
      • Volume: X units
    • Omnipod
      • Value: $X billion
      • Volume: X units
    • My life omnipod
      • Value: $X billion
      • Volume: X units
    • Others
      • Value: $X billion
      • Volume: X units

Pump Type vs. Application

  • Tethered Pump
    • Battery
      • Value: $X billion
      • Volume: X units
    • Insulin Set Insertion Devices
      • Value: $X billion
      • Volume: X units
    • Insulin Reservoir
      • Value: $X billion
      • Volume: X units
  • Patch Pump
    • Battery
      • Value: $X billion
      • Volume: X units
    • Insulin Set Insertion Devices
      • Value: $X billion
      • Volume: X units
    • Insulin Reservoir
      • Value: $X billion
      • Volume: X units

Pump Type vs. Disease Indication

  • Tethered Pump
    • Type 1 Diabetes
      • Value: $X billion
      • Volume: X units
    • Type 2 Diabetes
      • Value: $X billion
      • Volume: X units
  • Patch Pump
    • Type 1 Diabetes
      • Value: $X billion
      • Volume: X units
    • Type 2 Diabetes
      • Value: $X billion
      • Volume: X units

Pump Type vs. End User

  • Tethered Pump
    • Hospitals
      • Value: $X billion
      • Volume: X units
    • Clinics
      • Value: $X billion
      • Volume: X units
    • Homecare
      • Value: $X billion
      • Volume: X units
    • Laboratories
      • Value: $X billion
      • Volume: X units
  • Patch Pump
    • Hospitals
      • Value: $X billion
      • Volume: X units
    • Clinics
      • Value: $X billion
      • Volume: X units
    • Homecare
      • Value: $X billion
      • Volume: X units
    • Laboratories
      • Value: $X billion
      • Volume: X units

Pump Type vs. Geography

  • Tethered Pump
    • North America
      • U.S.
        • Value: $X billion
        • Volume: X units
      • Canada
        • Value: $X billion
        • Volume: X units
    • Europe
      • U.K.
        • Value: $X billion
        • Volume: X units
      • Germany
        • Value: $X billion
        • Volume: X units
      • France
        • Value: $X billion
        • Volume: X units
      • Rest of Europe
        • Value: $X billion
        • Volume: X units
    • Asia Pacific
      • China
        • Value: $X billion
        • Volume: X units
      • India
        • Value: $X billion
        • Volume: X units
      • Japan
        • Value: $X billion
        • Volume: X units
      • South Korea
        • Value: $X billion
        • Volume: X units
      • Rest of Asia Pacific
        • Value: $X billion
        • Volume: X units
    • Rest of the World
      • Value: $X billion
      • Volume: X units
  • Patch Pump
    • North America
      • U.S.
        • Value: $X billion
        • Volume: X units
      • Canada
        • Value: $X billion
        • Volume: X units
    • Europe
      • U.K.
        • Value: $X billion
        • Volume: X units
      • Germany
        • Value: $X billion
        • Volume: X units
      • France
        • Value: $X billion
        • Volume: X units
      • Rest of Europe
        • Value: $X billion
        • Volume: X units
    • Asia Pacific
      • China
        • Value: $X billion
        • Volume: X units
      • India
        • Value: $X billion
        • Volume: X units
      • Japan
        • Value: $X billion
        • Volume: X units
      • South Korea
        • Value: $X billion
        • Volume: X units
      • Rest of Asia Pacific
        • Value: $X billion
        • Volume: X units
    • Rest of the World
      • Value: $X billion
      • Volume: X units

Competitive Landscape

  • Market Share Analysis
  • Key Developments
  • Company Profiles
    • Medtronic Plc
    • Insulet Corporation
    • Medzer
    • Microport Scientific
    • Eoflow
    • Debiotech S.A.
    • Lenomed Medical
    • Microtech Medical
    • Cequr SA
    • F. Hoffmann La Roche AG
    • Ypsomed AG
    • Zealand Pharma
    • Terumo Corporation
    • Vicentra B.V.

Technological Analysis

  • Innovations in Insulin Pump Technology
  • Integration with Continuous Glucose Monitoring (CGM)
  • Development of Artificial Pancreas Systems

Regulatory Framework

  • Overview of Regulatory Bodies
  • Key Regulations and Guidelines
  • Impact of Regulatory Changes on the Market

Investment Analysis

  • Recent Investments
  • Mergers & Acquisitions
  • Partnership & Collaborations

Appendix

  • List of Abbreviations
  • Methodology
  • Primary Research Insights
  • Secondary Research Sources
  • Disclaimer

FAQ's

Answer : The insulin pump market is set for strong, steady growth, expanding at a CAGR of 9.65% from 2026 to 2035. Valued at USD 8.26 billion in 2026, it is projected to reach USD 18.93 billion by 2035.

Answer : Major trends include the rise of AI-powered closed-loop insulin systems, tighter integration with continuous glucose monitoring (CGM), and growing demand for patch pumps

Answer : Market leaders like Medtronic, Tandem Diabetes Care, and Insulet are driving innovation through AI-enabled pumps, CGM integration, and miniaturized designs.
Any Questions

Meet the Team

Rohan Patil is a seasoned market research professional with over 5+ years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

Learn more about Rohan Patil

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar